MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,150,000 | +69.9% | 60,633 | 0.0% | 0.02% | +56.2% |
| Q3 2019 | $3,032,000 | +37.1% | 60,633 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $2,211,000 | +30.4% | 60,633 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $1,695,000 | +46.0% | 60,633 | 0.0% | 0.01% | +250.0% |
| Q4 2018 | $1,161,000 | -36.5% | 60,633 | -0.8% | 0.00% | -60.0% |
| Q3 2018 | $1,828,000 | -18.5% | 61,120 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $2,243,000 | +35.1% | 61,120 | +21.3% | 0.01% | +20.0% |
| Q1 2018 | $1,660,000 | +20.6% | 50,383 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $1,377,000 | -26.2% | 50,383 | 0.0% | 0.01% | -33.3% |
| Q3 2017 | $1,866,000 | -2.6% | 50,383 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $1,915,000 | – | 50,383 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |